Submission of Press Release that is being issue by Curateq Biologics s .r.o a wholly owned step down subsidiary of the Company in connection with the receipt of positive opinion from CHMP for Dazubys a Trastuzumab Biosimilar.
26-अप्रैल-2025
डाउनलोड पीडीएफ़
Aurobindo Pharma
Submission of Press Release that is being issue by Curateq Biologics s .r.o a wholly owned step down subsidiary of the Company in connection with the receipt of positive opinion from CHMP for Dazubys a Trastuzumab Biosimilar.